A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

Table 6 Suggestion for the use of G-CSFs in individual cases. Usage of the GCSFs preparation for cervical cancer

	Q19. CCRT for cervical cancer^a
	n = 114
I recommend G-CSFs on the following day of chemotherapy	6 (5.2)^b
After Grade 4 neutropenia developed, I recommend G-CSFs	23 (20.2)
After FN developed, I recommend G-CSFs	26 (22.8)
I recommend G-CSFs to only high risk patients (Less than neutrophilic 100/mm³continues more than 10 days and/or fungal infectious disease)	35 (30.7)
I do not recommend G-CSFs	24 (21.1)

CCRT Concurrent Chemoradiotherapy, G-CSF Granulocyte-Colony Stimulating Factor, FN Febrile Neutropenia
^aA 30-year-old woman. We plan to concurrent chemoradiotherapy (cisplatin 40 mg/m² on days 1, 8, 15, 22, 29, and 36) in patients with stage IIB cervical cancer (squamous cell carcinoma)
^bNumber (percent)

ISSN: 2055-0294